Empire Genomics Awarded SBIR Phase I Grant from NCI for Companion Diagnostics for Multiple Myeloma

BUFFALO, N.Y., -- Empire Genomics, LLC has been awarded a Phase I SBIR Grant by the National Institute of Health/National Cancer Institute to develop a genomic companion diagnostic test for multiple myeloma (MM). This is the first SBIR grant Empire Genomics has been awarded and it will be funded through October 2013. The Company plans [...]

MOCON Announces Quarterly Dividend

MINNEAPOLIS-- MOCON, Inc. (NASDAQ: MOCO) announced today that on May 23, 2013, its Board of Directors declared a quarterly cash dividend of eleven cents ($0.11) per share, payable on August 16, 2013, to shareholders of record on August 2, 2013. The Company has provided stockholders with quarterly dividends for the 100th consecutive quarter. Prior to [...]

Marc Le Bozec joins CYTOO as Chief Executive Officer

Grenoble, France,– CYTOO, a French biotechnology company providing research and development tools based on cell architecture, welcomes Marc Le Bozec as Chief Executive Officer. For more than 15 years, Marc Le Bozec has been a major stakeholder in industrial and academic biotechnologies in France. For several years, he worked as a consultant in organization (Bossard [...]

Analytik Jena Receives Major Order for Diagnostic Detection Systems from Pakistan

Jena (Germany), – Analytik Jena AG has received a large order through its Leipzig-based subsidiary AJ Roboscreen GmbH requiring the delivery of systems for the preparation of samples and the detection of various viruses to eleven clinical laboratories in Pakistan. AJ Roboscreen GmbH secured the invitation to tender through a regional sales partner and prevailed [...]

General Data Acquires Triangle Biomedical Sciences

General Data Company Inc., a leading manufacturer and provider of barcode identification, tracking and data management products and solutions, has announced that it has acquired Triangle Biomedical Sciences Inc., (TBS) of Durham, North Carolina, a leading manufacturer and supplier of instrumentation, reagents and consumables for the clinical and research pathology marketplace. TBS will become a [...]

SCHOTT Introduces 10mL DURAN® Laboratory Bottle

SCHOTT North America, Inc. announced today the availability of the newest size of DURAN® Laboratory Bottles: 10 mL, the smallest in the Laboratory Bottle lineup. Ideal for a full array of uses, from storage through packaging, the new DURAN® 10mL Laboratory 3.3 borosilicate glass bottles exhibit excellent chemical resistance through the full temperature range. Ideal [...]

QIAGEN and China’s BioBAY open translational medicine center to accelerate creation of novel companion diagnostics

SUZHOU, China, and HILDEN, Germany, - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and SIP Biotech Development Co., Ltd. (BioBAY) today announced the opening of QIAGEN (Suzhou) Translational Medicine Center, a translational medicine R&D Corporation which aims to accelerate the discovery and validation of biomarkers, and to create companion diagnostics for the Chinese market. [...]

Asylum Research Announces Ben Ohler as AFM Business Manager

Asylum Research, an Oxford Instruments company, announces the appointment of Dr. Ben Ohler to the new position of Atomic Force Microscopy (AFM) Business Manager. Ohler will oversee the Asylum MFP-3D family of products as well as manage the strategic direction, new product development, and product marketing for the entire line. “We are very excited that [...]

First Large-Scale Population-Based Study in the U.S. Shows Hologic’s 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection

BEDFORD, Mass., -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that the first large-scale observational study in a U.S. clinical practice comparing breast cancer screening with Hologic's [...]

State Licensure Expands For BRAF Assay From Beckman Coulter Genomics

DANVERS, MASS. – The BRAF assay from Beckman Coulter Genomics has been granted clinical laboratory licenses in four states, expanding the availability of the offering that last year received CLIA Certificates of Registration and Compliance. Pennsylvania, Maryland and Rhode Island, three of the seven states that require statewide licensure in addition to CLIA certificates, have [...]

Access IBO on Knowledge Center